Hacker-Mira-APA-Table-RD4.pdfHacker-Mira-APA-RD4APA Research Paper (Mirano)Source: Diana Hacker (Boston: Bedford/St. Martin’s, 2006).Obesity in Children iCan Medication Cure Obesity in Children?A Review of the LiteratureLuisa MiranoPsychology 107, Section BProfessor KangOctober 31, 2004Short title andpage number forstudent papers.Lowercase roman numerals are usedon title page and abstract page,arabic numeralson all text pages.Full title, writer’sname, and sectionnumber of course,instructor’s name,and date (all cen-tered).XXXXMarginal annotations indicate APA-style formatting and effective writing.Source: Diana Hacker (Boston: Bedford/St. Martin’s, 2006).Abstract appears on a separate page.Source: Diana Hacker (Boston: Bedford/St. Martin’s, 2006).Full title, centered.The writer uses afootnote to definean essential termthat would be cum-bersome to definewithin the text.The writer sets up her organiza-tion by posing fourquestions.The writer statesher thesis.Source: Diana Hacker (Boston: Bedford/St. Martin’s, 2006).Headings, centered,help readers follow the organization.In a signal phrase,the word “and”links the names oftwo authors; thedate is given inparentheses.Because the author(Carmona) is notnamed in the signalphrase, his nameand the date appear in parenthe-ses, along with theparagraph numberof the electronicsource.Source: Diana Hacker (Boston: Bedford/St. Martin’s, 2006).Ellipsis mark indicates omittedwords.An ampersandlinks the names oftwo authors inparentheses.The writer drawsattention to an important article.Obesity in Children 4Table 1Effectiveness of Sibutramine and Orlistat in AdolescentsAverageweight Medication Subjects TreatmentaSide effects loss/gainSibutra-mineOrlistatControlMedi-catedControlMedi-cated0-6 mos.:placebo6-12 mos.:sibutra-mine0-12 mos.:sibutra-mine0-12 mos.:placebo0-12 mos.:orlistatMos. 6-12:increasedblood pres-sure; in-creasedpulse rateIncreasedblood pres-sure; in-creasedpulse rateNoneOily spot-ting; flatu-lence;abdominaldiscomfortAfter 6mos.: lossof 3.2 kg (7 lb)After 12mos.: lossof 4.5 kg(9.9 lb)After 6mos.: lossof 7.8 kg(17.2 lb)After 12mos.: lossof 7.0 kg(15.4 lb)Gain of0.67 kg(1.5 lb)Loss of 1.3kg (2.9 lb)Note. The data on sibutramine are adapted from “Behavior Therapy andSibutramine for the Treatment of Adolescent Obesity,” by R. I. Berkowitz, T. A. Wadden, A. M. Tershakovec, & J. L. Cronquist, 2003, Journal of the American Medical Association, 289, pp. 1807-1809. The data on orlistat are adapted from Xenical (Orlistat) Capsules: Complete Product Information,by Roche Laboratories, December 2003, retrieved from http://www.rocheusa.com/products/xenical/pi.pdf aThe medication and/or placebo were combined with behavioral therapy in all groups over all time periods.Source: Diana Hacker (Boston: Bedford/St. Martin’s, 2006).The writer uses atable to summa-rize the findingspresented in twosources.A note gives thesource of the data.A content note explains datacommon to allsubjects.Source: Diana Hacker (Boston: Bedford/St. Martin’s, 2006).When this articlewas first cited, allfour authors werenamed. In subse-quent citations ofa work with threeto five authors,“et al.” is usedafter the first author’s name.Source: Diana Hacker (Boston: Bedford/St. Martin’s, 2006).For a source withsix or more authors, the firstauthor’s surname followed by “et al.”is used for the first and subsequentreferences.Source: Diana Hacker (Boston: Bedford/St. Martin’s, 2006).The writer develops thepaper’s thesis.Source: Diana Hacker (Boston: Bedford/St. Martin’s, 2006).Brackets indicatea word not in theoriginal source.A quotation longerthan 40 words is set off from the text withoutquotation marks.The writer inter-prets the evidence;she doesn’t just report it.The tone of theconclusion is ob-jective.Obesity in Children 9While none of the medications currently available is a miracledrug for curing the nation’s 9 million obese children, researchhas illuminated some of the underlying factors that affect obe-sity and has shown the need for a comprehensive approach tothe problem that includes behavioral, medical, social, andpolitical change.Source: Diana Hacker (Boston: Bedford/St. Martin’s, 2006).Obesity in Children 10ReferencesBerkowitz, R. I., Wadden, T. A., Tershakovec, A. M., & Cron-quist, J. L. (2003). Behavior therapy and sibutramine for the treatment of adolescent obesity. Journal of theAmerican Medical Association, 289, 1805-1812.Carmona, R. H. (2004, March 2). The growing epidemic of child-hood obesity. Testimony before the Subcommittee onCompetition, Foreign Commerce, and Infrastructure of the U.S. Senate Committee on Commerce, Science, andTransportation. Retrieved from http://www.hhs.gov/asl/testify/t040302.htmlCritser, G. (2003). Fat land: How Americans became the fattestpeople in the world. Boston: Houghton Mifflin.Duenwald, M. (2004, January 6). Slim pickings: Looking beyond ephedra. The New York Times, p. F1. Retrievedfrom LexisNexis.Henry J. Kaiser Family Foundation. (2004, February). The roleof media in childhood obesity. Retrieved from http://www.kff.org/entmedia/7030.cfmHilts, P. J. (2002, March 20). Petition asks for removal of dietdrug from market. The New York Times, p. A26. Retrievedfrom LexisNexis.Hoppin, A. G., & Taveras, E. M. (2004, June 25). Assessmentand management of childhood and adolescent obesity.Clinical Update. Retrieved from http://www.medscape.com/viewarticle/481633 McDuffie, J. R., Calis, K. A., Uwaifo, G. I., Sebring, N. G., Fallon, E. M., Hubbard, V. S., et al. (2003). Three-month Source: Diana Hacker (Boston: Bedford/St. Martin’s, 2006).List of referencesbegins on a newpage. Heading is centered.List is alphabet-ized by authors’last names. All authors’ namesare inverted.The first line of an entry is at theleft margin; subsequent lines indent 1⁄2'' (or five spaces).Double-spacing isused throughout.Obesity in Children 11tolerability of orlistat in adolescents with obesity-related comorbid conditions. Obesity Research, 10, 642-650.Roche Laboratories. (2003, December). Xenical (orlistat) cap-sules: Complete product information. Retrieved fromhttp://www.rocheusa.com/products/xenical/pi.pdfYanovski, S. Z., & Yanovski, J. A. (2002). Drug therapy: Obesity.The New England Journal of Medicine, 346, 591-602.Source: Diana Hacker (Boston: Bedford/St. Martin’s,
View Full Document
Unlocking...